扩张型心肌病全基因组关联分析揭示3p25.1和22q11.23两个新位点
该研究在2719例扩张型心肌病(DCM)患者和4440例对照中开展迄今最大规模的全基因组关联研究,发现并复制了3p25.1和22q11.23两个新DCM相关位点,同时验证了BAG3和HSPB7两个已知位点。基于四个位点风险等位基因构建的遗传风险评分显示,携带8个风险等位基因者较5个者DCM风险增加3倍。功能分析提示SLC6A6和SMARCB1分别为两个新位点的候选基因。
要点
- 发现并复制了3p25.1(rs62232870)和22q11.23(rs7284877)两个新DCM相关位点。
- 四个位点风险等位基因的遗传风险评分可分层DCM风险,8个风险等位基因者风险增加3倍。
- SLC6A6和SMARCB1被分别鉴定为3p25.1和22q11.23位点的最可能候选基因。
核心结论
- 研究揭示了DCM的遗传结构,发现两个新易感位点并提示SLC6A6和SMARCB1参与疾病发生。
研究设计与样本
- 全基因组关联研究,发现阶段纳入2719例DCM患者和4440例对照,并进行复制验证。
主要发现
- 3p25.1位点lead SNP rs62232870的P值在发现阶段为8.7×10^-11,复制阶段为7.7×10^-4。
- 22q11.23位点lead SNP rs7284877的P值在发现阶段为3.3×10^-8,复制阶段为1.4×10^-3。
- 验证了染色体10和1上先前识别的DCM位点BAG3和HSPB7。
- 基于四个DCM位点风险等位基因数的遗传风险评分显示,携带8个风险等位基因者较5个者DCM风险增加3倍。
- 生物信息学注释和iPSC来源心肌细胞的4C测序分析提示SLC6A6为3p25.1位点最可能的DCM基因,22q11.23位点候选基因为SMARCB1。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Our objective was to better understand the genetic bases of dilated cardiomyopathy (DCM), a leading cause of systolic heart failure. METHODS AND RESULTS: We conducted the largest genome-wide association study performed so far in DCM, with 2719 cases and 4440 controls in the discovery population. We identified and replicated two new DCM-associated loci on chromosome 3p25.1 [lead single-nucleotide polymorphism (SNP) rs62232870, P = 8.7 × 10-11 and 7.7 × 10-4 in the discovery and replication steps, respectively] and chromosome 22q11.23 (lead SNP rs7284877, P = 3.3 × 10-8 and 1.4 × 10-3 in the discovery and replication steps, respectively), while confirming two previously identified DCM loci on chromosomes 10 and 1, BAG3 and HSPB7. A genetic risk score constructed from the number of risk alleles at these four DCM loci revealed a 3-fold increased risk of DCM for individuals with 8 risk alleles compared to individuals with 5 risk alleles (median of the referral population). In silico annotation and functional 4C-sequencing analyses on iPSC-derived cardiomyocytes identify SLC6A6 as the most likely DCM gene at the 3p25.1 locus. This gene encodes a taurine transporter whose involvement in myocardial dysfunction and DCM is supported by numerous observations in humans and animals. At the 22q11.23 locus, in silico and data mining annotations, and to a lesser extent functional analysis, strongly suggest SMARCB1 as the candidate culprit gene. CONCLUSION: This study provides a better understanding of the genetic architecture of DCM and sheds light on novel biological pathways underlying heart failure.
引用
- Garnier S, Harakalova M, Weiss S, et al. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23. Eur Heart J. 2021. PMID: 33677556. doi:10.1093/eurheartj/ehab030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。